Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type 2 immunity‐driven diseases: Towards a multidisciplinary approach
D. Hassoun, O. Malard, S. Barbarot, et al.
Clinical & Experimental Allergy (2021) Vol. 51, Iss. 12, pp. 1538-1552
Open Access | Times Cited: 22

Showing 22 citing articles:

In the Thick of It: Formation of the Tuberculous Granuloma and Its Effects on Host and Therapeutic Responses
Mark R. Cronan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58
Spanish Consensus on Remission in Asthma (REMAS)
Francisco Javier Álvarez Gutiérrez, Francisco Casas Maldonado, José Gregorio Soto Campos, et al.
Archivos de Bronconeumología (2024) Vol. 60, Iss. 8, pp. 503-509
Closed Access | Times Cited: 12
White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA
Louise De Prins, Ulrike Raap, Tara Mueller, et al.
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 27
Prevalence of chronic rhinosinusitis without/with nasal polyps according to severity in Spain
J Mullol, J. Sastre, Javier Domínguez‐Ortega, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 5
Cytokines in Allergic Conjunctivitis: Unraveling Their Pathophysiological Roles
DeGaulle I. Chigbu, Nicholas J. Karbach, Sampson Listowell Abu, et al.
Life (2024) Vol. 14, Iss. 3, pp. 350-350
Open Access | Times Cited: 4
Hypoxia‐Inducible Factor 1 Alpha Potentiates Lipopolysaccharide‐Induced Expression of IL‐13 and IL‐33 in Mast Cells Under Hypoxia
Norika Chiba, Tomokazu Ohnishi, Tetsuya Matsuguchi
Microbiology and Immunology (2025)
Closed Access
Combination of Biological Therapy in Severe Asthma: Where We Are?
Lorenzo Carriera, Marta Fantò, Alessia Martini, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1594-1594
Open Access | Times Cited: 10
From trained immunity in allergy to trained immunity‐based allergen vaccines
Leticia Martín‐Cruz, Carmen Sevilla‐Ortega, Alba Angelina, et al.
Clinical & Experimental Allergy (2022) Vol. 53, Iss. 2, pp. 145-155
Open Access | Times Cited: 13
Multidisciplinary management of type 2 inflammation diseases using a screening tool
Óscar Palomares, Carolina Cisneros, F.J. Ortiz de Frutos, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 2
Meeting the Needs of Patients With Atopic Dermatitis: A Multidisciplinary Approach
Filomena Russo, Francesco Santi, Vittoria Cioppa, et al.
Dermatitis (2022) Vol. 33, Iss. 6S, pp. S141-S143
Closed Access | Times Cited: 8
Skin Lipid Barrier: Structure, Function and Metabolism
Evgeny Berdyshev
Allergy Asthma and Immunology Research (2024) Vol. 16, Iss. 5, pp. 445-445
Open Access | Times Cited: 1
Targeting of the IL-5 pathway in severe asthma reduces mast cell progenitors
Perla Abigail Alvarado‐Vázquez, Erika Méndez-Enríquez, Maya Salomonsson, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 1
Race science without racists: how bigoted paradigms persist in allergy research
Ian A. Myles
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Addressing the unmet needs in patients with type 2 inflammatory diseases: when quality of life can make a difference
Enrique Gómez de la Fuente, Isam Alobid, Íñigo Ojanguren, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 2
Role of Mast Cells in Eosinophilic Gastrointestinal Diseases
Paneez Khoury, Joshua B. Wechsler
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 2, pp. 311-327
Closed Access
Severity Assessment and IL-5 Evaluation after Immunotherapy in Atopic Dermatitis Mice
Sylvia Anggraeni, Dinar Chieko Triesayuningtyas, Hamidah Luthfidyaningrum, et al.
Advancements in Life Sciences (2024) Vol. 11, Iss. 2, pp. 309-309
Open Access
Desarrollo Infantil: Una Perspectiva Integral desde la Pediatría: Child Development: A Comprehensive Perspective from Pediatrics
Cecilia Alejandra García Ríos, Byron Ernesto Coello Franco, Anthony Ortega, et al.
(2024)
Open Access
Preclinical Development of SHR-1819, a Potent Humanized IL-4Rα Antibody for Treating Type 2 Inflammatory Diseases
Guolin Zhao, Zhijun Wang, Jun Zhang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6375-6388
Open Access
Climate Change and Allergic Diseases: A scoping review
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
The Journal of Climate Change and Health (2024), pp. 100350-100350
Open Access
A Multidisciplinary Approach for Type 2 Allergic Diseases: What Do Biologics Teach Us?
Mauro Maniscalco, Aikaterini Detoraki, Giovanni Sarnelli, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 6, pp. 941-941
Open Access | Times Cited: 1
Influence of the Th1 Cytokine Environment on CCL5 Production from Langerhans Cells
Katsuhiko Matsui, R. Shibata, Kotone Mogi
Biological and Pharmaceutical Bulletin (2022) Vol. 45, Iss. 4, pp. 491-496
Open Access | Times Cited: 2
Page 1

Scroll to top